Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients
NCT04885907
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Vaccine Response Impaired
Immune Suppression
Covid19
Interventions
BIOLOGICAL:
mRNA-1273 vaccine
OTHER:
Normal Saline Placebo
Sponsor
University Health Network, Toronto